A new meta-analysis examines the effects of dual antiplatelet therapy after thrombolysis in minor stroke patients. Findings ...

Intravenous. The authors have no relevant ... It is questionable whether individualized antiplatelet therapy should be based on genetic testing, platelet function testing or both.

Aggressive antiplatelet therapy included oral or intravenous glycoprotein (GP) IIb/IIIa or P2Y12 inhibitors. The primary outcome was cervical carotid artery patency at day 1 imaging follow-up. Results ...

Anticoagulants and antiplatelet agents pose a great risk ... patients may or may not be required to cease warfarin therapy, depending on the type of surgery. However, if the risk of VTE outweighs ...

Grifols, a global healthcare company and leading producer of plasma-based medicines, developed the novel intravenous immunoglobulin (IVIG) treatment called Flebogamma 5% DIF. IVIG involves ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...

Blogging Stroke highlights high-impact studies published in the journal Stroke. In addition to article summaries, Blogging Stroke includes interviews with authors of recently published Stroke articles ...

Keywords: Dual Antiplatelet Therapy (DAPT), Drug-Coated Balloons (DCB), Cardiovascular Interventions, Antithrombotic Therapies, Coronary Artery Disease (CAD) Important note: All contributions to this ...